The People Behind
Our Inventions
Co-founder / Chief Medical Officer
Dr. Chang-Wook Jeong, M.D., Ph.D.
-
Inventor of HyperQure and clinical innovator leading the future of minimally invasive surgery.
-
Professor of Urology at Seoul National University Hospital (SNUH). Leads SNUH’s Innovative Medical Technology Research Institute and has filed over 30 patents in surgical technology. Also serves as CIO and Director of Hospital Information at SNUH.
-
Experienced in medical device startups, technology transfer, and clinical commercialization.
Co-founder / Chairman
Chan-Ho Park
-
Veteran investor and M&A advisor with over two decades of experience in global finance, including leadership roles across private equity, investment banking, and cross-border transactions.
-
Managing Partner at CP Partners. Previously held senior roles at Mount Kellett Capital, Warburg Pincus, and Goldman Sachs. Brings 25+ years of cross-border transaction experience with deep insight into medtech growth strategy.
Chief Executive Officer
Kee-Wan Kim
-
Global medtech executive with 25+ years of device development and commercialization leadership.
-
Former Head of PMO at both Medytox and Siemens Healthineers, and Program Manager at GE Healthcare.
-
Extensive experience in launching and scaling medical technologies from R&D through global market deployment.
Global VP / Clinical & Regulatory Affairs
Ae-Young Woo
-
Clinical trial and regulatory specialist with 25+ years of hands-on experience and global consulting background.
-
Previously Director at IQVIA and Synex Consulting, leading medical device trial operations across Korea and APAC. Brings rare perspective across global regulatory landscapes and clinical site execution.
-
Licensed nurse in Korea, New Zealand, and the U.S.
Global VP / Clinical & Regulatory Affairs
Jason G. Jones
-
Clinical and regulatory expert with over 20 years of experience leading FDA-regulated trials across neuromodulation, cardiovascular, orthopedics, and aesthetics
-
Held leadership roles at Zimmer, Bard, Smith & Nephew, LivaNova, Newronika, InnovHeart, and SoniVie
-
Brings deep expertise in early-stage trial execution and accelerating global regulatory progress
Medical Director
Dr. Jae-Hung Jung, M.D., Ph.D.
-
Evidence-based medical scientist guiding clinical validation at DeepQure.
-
Professor at Yonsei University College of Medicine in Urology and Precision Medicine. PI on multiple national clinical guideline projects and digital health studies, with publications in top-tier medical journals.
Chief Financial Officer
Jong-Sun Park
-
Finance strategist with 20+ years of experience in investment banking and M&A deal execution.
-
Executive Director at CP Partners. Formerly with ORIX Corporation and Daiwa SMBC Securities. Brings deep expertise in corporate finance, capital markets, and cross-border transactions.
Chief Technology Officer
Young-Il Yoon
-
Medical device engineer with experience in surgical robotics and ultrasound systems.
-
Led mechanical design for surgical robots at Meere Company and R&D for HIFU systems at Alpinion Medical.
Director of Engineering
Du-Jin Bach
-
Systems integration expert with deep R&D experience across hospitals, startups, and national labs.
-
Former CTO at LIVSMED and principal engineer at Korea’s National Cancer Center. Specializes in full-stack device development from prototyping to pre-clinical testing.